Cinven agrees to buy majority stake in Germany's synlab

Cinven did not disclose the size of the transaction in a statement.

Reuters reported on Thursday that Cinven would pay 1.7-1.8 billion euros ($3.92 billion) for synlab, according to three sources familiar with the deal.

The purchase follows Cinven's acquisition in May of French medical diagnostics provider Labco (LABCO.PA) for 1.2 billion euros.

Cinven said the combined businesses would benefit from geographical diversification and would have the strongest medical capabilities in Europe.

($1 = 0.8927 euros)

(Reporting by Carolyn Cohn; Editing by Matt Scuffham)